PHARMABIO DEVELOPMENT INC
Insider
First SEC filing: April 14, 2010 · Latest: April 14, 2010
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 12, 2012 | CRMD | S | 11,000 | $0.45 | $4,950 | 778,563 Direct | -1.39% | Disposed | 219.6% (price as of 2026-10-02) |
| March 30, 2010 | CRMD | C | 394,781 | · | · | 394,781 Direct | · | Acquired | (price as of 2026-10-02) |
| March 30, 2010 | CRMD | C | 394,781 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 30, 2010 | CRMD | C | 789,563 | · | · | 789,563 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 30, 2010 | CRMD | Warrants issued as part of Units | Common Stock, $0.001 par balue per share | $3.44 | March 24, 2015 | 394,781 | Acquired |
| March 30, 2010 | CRMD | 12% Convertible Notes | Units consisting of common stock and warrant [F3] | · | · | 394,781 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 14, 2010 | CRMD | 12% Convertible Notes | · | Direct |